| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |